Skip to main navigation Skip to search Skip to main content

The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomised double‐blind placebo‐controlled trial

  • Clare A. Whicher
  • , Hermione C. Price
  • , Peter Phiri
  • , Shanaya Rathod
  • , Katharine Barnard‐Kelly
  • , Kandala Ngianga
  • , Kerensa Thorne
  • , Carolyn Asher
  • , Robert C. Peveler
  • , Joanne McCarthy
  • , Richard I. G. Holt

    Research output: Contribution to journal › Article › peer-review

    633 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomised double‐blind placebo‐controlled trial'. Together they form a unique fingerprint.
    Sort by

    INIS

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science